Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.
Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients.
Cavernoma of the conus medullaris mimicking transverse myelitis.
Multiple sclerosis, blood flow, and CSF circulation.
Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
Multiple sclerosis: clinical features and MRI findings in Northern China.
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
CCR2+CCR5+ T Cells Producing Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis.
Postinfectious neurologic syndromes: A prospective cohort study.
Structural connectomics in brain diseases.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
Multiple sclerosis: On the TRAIL of IFN-β response.
PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells.
The radiologically isolated syndrome.
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

Pages